Cancer IQ Inc. — SEC Form D Filing

Cancer IQ Inc. filed an SEC Form D on May 26, 2026, reporting $4.28M raised in Healthcare Technology.

Form D filing details

Filing
SEC Form D
Filing date
May 26, 2026
Amount reported
$4.28M
Round stage
Series A
Industry
Healthcare Technology
Website
https://www.canceriq.com/

What the company does

Securities: Debt. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Health systems face challenges in effectively providing access to cancer genomics and high-risk services, often missing patients and being burdened by administrative tasks, leading to inefficiencies and missed opportunities in cancer care.

Solution

CancerIQ provides a precision health intelligence platform that improves access to cancer prevention and treatment by automating workflows, integrating with EHRs, enabling genomic and genetic counseling, and supporting decision-making with evidence-based guidelines and risk models.

Verdict

Investors decided to back CancerIQ because they recognized the urgent need for innovation in cancer care, not solely as a response to technological advancements in genomics. Their bet hinged on increasing operational efficiencies in healthcare systems to enhance patient access and care outcomes, suggesting belief in the scalability of CancerIQ's platform. However, the limited upside comes from the crowded landscape, where existing players have already established robust footholds, which may dilute potential market differentiation over time.

Source: SEC EDGAR Form D filing